WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trisalus Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Emmett YoungChief Financial Officer2025-05-1913,175$5.18
$68.25kBuy
Bryan F. CoxChief of Research2025-05-194,764$5.18
$24.68kSell
Jodi DevlinChief of Clinical Operations2025-05-1924,131$5.18
$125.00kBuy
Jodi DevlinChief of Clinical Operations2025-05-194,764$5.18
$24.68kSell
Richard MarshakChief Commercial Officer2025-05-1921,428$5.18
$111.00kBuy
Richard MarshakChief Commercial Officer2025-05-196,597$5.18
$34.17kSell
Sean MurphyDirector2025-05-1944,884$5.18
$232.50kBuy
Jennifer StevensChief Regulatory Officer2025-05-1928,455$5.18
$147.40kBuy
Jennifer StevensChief Regulatory Officer2025-05-198,704$5.18
$45.09kSell
Bryan F. CoxChief of Research2025-05-1915,722$5.18
$81.44kBuy

1 of 2

TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLSI insiders and whales buy or sell their stock.

TLSI Shareholders

What type of owners hold Trisalus Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medtech Acquisition Sponsor LLC12.51%6,249,999$42.12MInsider
Equity Ab Frankenius12.47%6,230,748$42.00MInsider
Mats Wahlstrom5.33%2,665,202$17.96MInsider
Kerry R. Hicks4.58%2,289,199$15.43MInsider
Nantahala Capital Management LLC4.08%2,040,245$13.75MInstitution
Awm Investment Company Inc2.50%1,250,000$8.43MInstitution
Vanguard Group Inc2.32%1,159,575$7.82MInstitution
Gilder Gagnon Howe Co LLC2.10%1,047,059$7.06MInstitution
David J. Matlin1.89%941,944$6.35MInsider
Blackrock Inc1.58%787,864$5.31MInstitution

1 of 3

TLSI vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLSI19.19%42.93%Net Buying
DCTH42.61%57.39%Net BuyingNet Buying
BWAY14.34%0.00%
CERS73.92%7.21%Net SellingNet Selling
QTRX64.97%35.03%Net BuyingNet Buying
View Top Medical Device Stocks

Trisalus Life Sciences Stock Ownership FAQ

Who owns Trisalus Life Sciences?

Trisalus Life Sciences (NASDAQ: TLSI) is owned by 19.19% institutional shareholders, 42.93% Trisalus Life Sciences insiders, and 37.88% retail investors. Medtech Acquisition Sponsor LLC is the largest individual Trisalus Life Sciences shareholder, owning 6.25M shares representing 12.51% of the company. Medtech Acquisition Sponsor LLC's Trisalus Life Sciences shares are currently valued at $43.19M.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.